A detailed history of Gw&K Investment Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,135,393 shares of INSM stock, worth $88 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
1,135,393
Previous 1,153,515 1.57%
Holding current value
$88 Million
Previous $84.2 Million 6.91%
% of portfolio
0.67%
Previous 0.72%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

SELL
$66.29 - $76.63 $1.2 Million - $1.39 Million
-18,122 Reduced 1.57%
1,135,393 $78.4 Million
Q3 2024

Nov 07, 2024

BUY
$62.0 - $79.01 $24.3 Million - $31 Million
391,783 Added 51.43%
1,153,515 $84.2 Million
Q2 2024

Aug 12, 2024

SELL
$22.0 - $69.71 $11.2 Million - $35.4 Million
-508,166 Reduced 40.02%
761,732 $51 Million
Q1 2024

May 08, 2024

SELL
$25.72 - $29.94 $562,599 - $654,907
-21,874 Reduced 1.69%
1,269,898 $34.5 Million
Q4 2023

Feb 09, 2024

SELL
$23.42 - $31.74 $1.42 Million - $1.92 Million
-60,497 Reduced 4.47%
1,291,772 $40 Million
Q3 2023

Nov 09, 2023

SELL
$19.86 - $26.93 $19,760 - $26,795
-995 Reduced 0.07%
1,352,269 $34.1 Million
Q2 2023

Aug 09, 2023

BUY
$16.44 - $21.1 $793,230 - $1.02 Million
48,250 Added 3.7%
1,353,264 $28.6 Million
Q1 2023

May 09, 2023

BUY
$16.26 - $21.73 $5.03 Million - $6.72 Million
309,237 Added 31.05%
1,305,014 $22.3 Million
Q4 2022

Feb 10, 2023

BUY
$16.98 - $23.15 $12.8 Million - $17.5 Million
755,076 Added 313.7%
995,777 $19.9 Million
Q3 2022

Nov 09, 2022

SELL
$20.88 - $28.21 $62,159 - $83,981
-2,977 Reduced 1.22%
240,701 $5.19 Million
Q2 2022

Aug 09, 2022

SELL
$17.07 - $25.71 $49,673 - $74,816
-2,910 Reduced 1.18%
243,678 $4.81 Million
Q1 2022

May 09, 2022

SELL
$20.42 - $28.13 $61,770 - $85,093
-3,025 Reduced 1.21%
246,588 $5.8 Million
Q4 2021

Feb 11, 2022

BUY
$25.89 - $33.45 $568,363 - $734,327
21,953 Added 9.64%
249,613 $6.8 Million
Q3 2021

Nov 10, 2021

BUY
$22.46 - $29.47 $1.66 Million - $2.18 Million
73,870 Added 48.03%
227,660 $6.27 Million
Q2 2021

Aug 10, 2021

SELL
$24.17 - $36.01 $81,211 - $120,993
-3,360 Reduced 2.14%
153,790 $4.38 Million
Q1 2021

May 11, 2021

SELL
$32.28 - $44.3 $35,475 - $48,685
-1,099 Reduced 0.69%
157,150 $5.35 Million
Q4 2020

Feb 05, 2021

BUY
$31.45 - $40.54 $4.98 Million - $6.42 Million
158,249 New
158,249 $5.27 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.5B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.